Stay updated on Anifrolumab SubQ in Lupus Adults Clinical Trial
Sign up to get notified when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.

Latest updates to the Anifrolumab SubQ in Lupus Adults Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference10%
- Check22 days agoChange DetectedUpdated software version from v3.0.2 to v3.1.0, indicating a minor revision without affecting core content or capabilities.SummaryDifference0.2%
- Check30 days agoChange DetectedAdds new recent dates and study status; removes an older date, refining time-sensitive information.SummaryDifference1.0%
- Check37 days agoChange DetectedUpdated from Revision: v3.0.1 to v3.0.2 and removed the 'Back to Top' link; no substantive changes to core content or pricing.SummaryDifference0.6%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.6%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as numerous updates to study statuses and contact information. However, several location-related terms and details have been removed.SummaryDifference39%
Stay in the know with updates to Anifrolumab SubQ in Lupus Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anifrolumab SubQ in Lupus Adults Clinical Trial page.